Effect of IIb-IIIa glycoprotein inhibitors in a partial limb amputation model submitted to warm ischemia in rats

Journal of Reconstructive Microsurgery

Volumn 25, Issue 5, 2009, Pages 283-288

  Cunha, Marcelo Sacramento ^a   Da Silva, José Carlos Faes ^b   Nakamoto, Hugo Alberto ^b   Machado, Fillipe Almeida ^a   Ferreira, Marcus Castro ^b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

No reflow phenomenon; Platelet; Rat limb

Indexed keywords

ABCIXIMAB; AGRASTAT; FIBRINOGEN RECEPTOR ANTAGONIST; OXYGEN RADICAL; SODIUM CHLORIDE; TIROFIBAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; EDEMA; LEG ISCHEMIA; LIMB AMPUTATION; LIMB SALVAGE; MALE; MICROCIRCULATION; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; THROMBOSIS; VASCULAR PATENCY;

AMPUTATION; ANIMALS; ANTIBODIES, MONOCLONAL; HINDLIMB; IMMUNOGLOBULIN FAB FRAGMENTS; LIMB SALVAGE; MALE; MICROCIRCULATION; MODELS, ANIMAL; NO-REFLOW PHENOMENON; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RATS; RATS, WISTAR; TYROSINE; WARM ISCHEMIA;

EID: 67649832004     PISSN: 0743684X     EISSN: 10988947     Source Type: Journal    
DOI: 10.1055/s-0029-1202552     Document Type: Article

References (40)

1. Ferreira MC, Leão PP. Experimental reimplantation of limb with vascular microsurgery. AMB Rev Assoc Med Bras 1977;23:3-6
2. Sapega AA, Heppenstall RB, Sokolow DP, et al. The bioenergetics of preservation of limbs before replantation. J Bone Joint Surg Am 1988;70:1500-1513
3. Cunha MS, da Silva JCF, Nakamoto H, Ferreira MC. Study of warm ischemia followed by reperfusion on a lower limb model in rats: effect of allopurinol and streptokinase. Clinics 2005;60:213-220
4. Morgan RF, Reisman NR, Curtis RM. Preservation of upper extremity devascularizations and amputations for replantation. Am Surg 1982;48:481-483 (Pubitemid 12067969)
5. Tanner NSB, McGrouther DA, Webster MHC. Survival after replantation. Br Med J (Clin Res Ed) 1982;285:1481-1483 (Pubitemid 13232152)
6. Prada FS, Arrunategui G, Alves MC, et al. Effect of allopurinol, superoxide-oxidase, and hyperbaric oxygen on flap survive. Microsurgery 2002;22:352-360 (Pubitemid 36055801)
7. May JW, Chait LA, O'Brien B. The no reflow phenomenon in experimental free flaps. Plast Reconstr Surg 1978;61:256-267 (Pubitemid 8277578)
8. Ames A, Wrigth R, Kowoda M, et al. Cerebral ischemia. The no-reflow phenomenon. Am J Pathol 1968;52:437-453
9. Nanobashivili J, Neumayer C, Fuegl A, et al. Ischemia/reperfusion injury of skeletal muscle: mechanisms, morphology, treatment strategies, and clinical applications. Eur Surg 2002;34:83-89 (Pubitemid 36223358)
10. Pang CY, Forrest CR, Mounsey R. Pharmacologic intervention in ischemia-induced reperfusion injury in the skeletal muscle. Microsurgery 1993;14:176-182 (Pubitemid 23131361)
11. Nanobashvili J, Neumayer C, Fugl A, et al. Ischemia/reperfusion injury of skeletal muscle: plasma taurine as a measure of tissue damage. Surgery 2003;133:91-100 (Pubitemid 36183131)
12. Huk I, Brovkovych V, Nanobashivili J, et al. Bioflavonoid quercitin scavenges superoxide and increases nitric oxide concentration in ischemia-reperfusion injury: an experimental study. Br J Surg 1998;85:1080-1085 (Pubitemid 28360771)
13. Grace PA. Ischemia-reperfusion injury. Br J Surg 1994;81:637-647
14. Russell RC, Roth AC, Kucan JO, et al. Reperfusion injury and oxygen free radicals. J Reconstr Microsurg 1989;5:79-89 (Pubitemid 19075188)
15. Klein MB, Chan PH, Chang J. Protective effects of superoxide dismutase against ischemia reperfusion injury: development and application of a transgenic animal model. Plast Reconstr Surg 2003;111:251-255 (Pubitemid 36015186)
16. Sundin BM, Hussein MA, Glasofer S, et al. The role of allopurinol and deferoxamine in preventing pressure ulcers in pigs. Plast Reconstr Surg 2000;105:1408-1421 (Pubitemid 30169475)
17. Stewart JR, Blackwell WH, Crule SL, et al. Prevention of myocardial ischemia reperfusion injury with oxygen free radicals scavengers. Surg Forum 1982;33:317
18. Fridovich I. Superoxide radical: an endogenous toxicant. Annu Rev Pharmacol Toxicol 1983;23:239-257
19. Manson PM, Anthenelli RM, Im MJ, et al. The role of oxygen-free radicals in ischemic tissue injury in island skin flaps. Ann Surg 1983;198:87-90
20. Aikens J, Dix TA. Perhydroxil radical (HOO) initiated lipid peroxidation. J Biol Chem 1991;266:15091-15098
21. Cunha MS, da Silva JCF, Nakamoto H, Fels KW, Ferreira MC. Venous occlusion after limb replantation: a new experimental model in rats. Rev Soc Bras Cir Plast 2005;20:155-159
22. Cunha MS, da Silva JCF, Nakamoto H, Simão DT, Ferreira MC. Effect of allopurinol and hyperbaric oxygen therapy in a limb replantation model after warm ischemia in rats. Rev Col Bras Cir 2005;32:64-68
23. Cunha MS, da Silva JCF, Nakamoto H, Fels KW, Ferreira MC. Effects of streptokinase and hyperbaric oxygen therapy on venous occlusion after limb replantation in rats. Rev Assoc Med Bras 2007;53:29-33
24. Miller SH, Lung RJ, Graham WP, et al. The acute effects of tourniquet ischemia on tissue and blood gas tensions in the primate limb. J Hand Surg Am 1978;3:11-20 (Pubitemid 8283398)
25. Chait LA, May JW, O'Brie BM, et al. The effects of perfusion of various solutions of the no-reflow phenomenon in experimental free flaps. Plast Reconstr Surg 1978;61:421
26. Urbaniak JR, Seaber AV, Chen LE. Assessment of ischemia and reperfusion injury. Clin Orthop Relat Res 1997;334:30-36 (Pubitemid 27034872)
27. Stock W, Bohn HJ, Isselhard W. Metabolic changes in rat skeletal muscle after acute arterial occlusion. Vasc Surg 1971;5:249-255
28. Swartz WM, Cha CJM, Ambler M, et al. Prolonged ischemia in the replanted rat leg: a biochemical and morphologic study with microvascular techniques. Surg Forum 1976;27:565-568 (Pubitemid 8006083)
29. Zdeblick TA, Shaffer JW, Field GA. An ischemia-induced model of revascularization failure of replanted limbs. J Hand Surg Am 1985;10:125-131 (Pubitemid 16091584)
30. Edwards RJ, Im MJ, Hoopes JE. Effects of hyperbaric oxygen preservation on rat limb replantation: a preliminary report. Ann Plast Surg 1991;27:31-35
31. Concannon MJ, Dooley TW, Puckett CL. Improved survival in a replantation model containing ischemic muscle. Microsurgery 1991;12:18-22
32. Olivas TP, Saylor TF, Wong HP, et al. Timing of microcirculatory injury from ischemia reperfusion. Plast Reconstr Surg 2001;107:785-788 (Pubitemid 32180126)
33. Basile AP, Fiala TGS, Yaremchuk MJ, May JW Jr. The antithrombotic effects of ticlopidine and aspirin in a microvascular thrombogenic model. Plast Reconstr Surg 1995;95:1258-1264
34. Coller BS. A new murine monoclonal antibody reports on activation-dependent change in the conformation and/or microenvironment for the platelet glycoprotein IIb/IIIa complex. J Clin Invest 1985;76:101-108 (Pubitemid 15240423)
35. Tcheng JE, Ellis SG, George BS, et al. Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin anti-platelet antibody Fab 7E3 in high-risk coronary angioplasty. Circulation 1994;90:1757-1764 (Pubitemid 24320922)
36. Barrett JS, Murphy G, Peerlinck K, et al. Pharmacokinetics and pharmacodynamics of MK-383, a selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist, in healthy men. Clin Pharmacol Ther 1994;56:377-388 (Pubitemid 24339084)
37. Kuo YR, Jeng SF, Wang FS, Huang HC, Wei FC, Yang KD. Platelet glycoprotein IIb/IIIa receptor antagonist (Abciximab) inhibited platelet activation and promoted skin flap survival after ischemia/reperfusion injury. J Surg Res 2002;107:50-55 (Pubitemid 35191812)
38. Sassoli PM, Emmell EL, Tam SH, et al. 7E3F(ab′)2 an effective antagonist of rat αIIbβ3, blocks in vivo thrombus formation and in vitro angiogenesis. Thromb Haemost 2001;85:896-902
39. Vickers S, Theoharides AD, Arison B, et al. In vitro and in vivo studies on the metabolism of tirofiban. Drug Metab Dispos 1999;27:1360-1366
40. Aguirre FV, Topol EJ, Ferguson JJ, Anderson K, et al. Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. Circulation 1995;91:2882-2890